FDA Drug Shortages

Current and Resolved Drug Shortages and Discontinuations Reported to FDA

Report a Drug Shortage | Contact Us | FAQ | Background Info | Get Email Alerts | Download Current Drug Shortages

Start Over | Back to Previous Screen

Semaglutide (Ozempic) Injection
Status: Currently in Shortage
»Date first posted: No date available
»Therapeutic Categories: Endocrinology/Metabolism

Expand all

Novo Nordisk, Inc. (Revised 03/17/2023)

Company Contact Information:
866-696-4090 and press 0

Presentation	Availability and Estimated Shortage Duration	Related Information	Shortage Reason (per FDASIA)
Ozempic® semaglutide injection, 0.25 mg / 0.5mg 2 mg/1.5mL (NDC 0169-4132-12)	To be discontinued	Transition to Ozempic® semaglutide injection, 0.25 mg / 0.5mg 2 mg/3mL
Ozempic® semaglutide injection, 1 mg (NDC 0169-4130-13)	Currently available
Ozempic® semaglutide injection, 2 mg (NDC 0169-4772-12)	Limited availability, may not fully meet demand until end of March 2023
Ozempic® semaglutide injection, 0.25 mg / 0.5mg 2 mg/3mL (NDC 0169-4181-13)	Currently available